Drug Discovery and Development Analysis & Statistics in North America Countries, December 2014

You might be interested in: Clinical Trial, Drug Discovery, Drug Development, more »

1-50 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

HIV-1 Infection Global Clinical Trials Review, H2, 2014

HIV-1 Infection Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • November 2014
  • by Global Data

HIV-1 Infection Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “HIV-1 Infection Global Clinical Trials Review, H2, 2014" provides data on the HIV-1 Infection clinical ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States

Barbados Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From January 01, 2009 To January 01, 2009
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

  • Industries : Drug Discovery and Development
  • Countries : Barbados
Chlamydia Infections Global Clinical Trials Review, H2, 2014

Chlamydia Infections Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • November 2014
  • by Global Data

Chlamydia Infections Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Chlamydia Infections Global Clinical Trials Review, H2, 2014" provides data on the Chlamydia ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Kawasaki Disease Global Clinical Trials Review, H2, 2014

Kawasaki Disease Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • October 2014
  • by Global Data

Kawasaki Disease Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Kawasaki Disease Global Clinical Trials Review, H2, 2014" provides data on the Kawasaki Disease clinical ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2014

Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • October 2014
  • by Global Data

Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Chediak-Higashi Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Chediak-Higashi ...

  • Industries : Drug Discovery and Development
  • Countries : United States, World
Lambert-Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, 2014

Lambert-Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • October 2014
  • by Global Data

Lambert-Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Lambert-Eaton Myasthenic Syndrome (LEMS) Global Clinical Trials Review, H2, ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Lung Transplantation Global Clinical Trials Review, H2, 2014

Lung Transplantation Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • October 2014
  • by Global Data

Lung Transplantation Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Lung Transplantation Global Clinical Trials Review, H2, 2014" provides data on the Lung Transplantation ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014

Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • October 2014
  • by Global Data

Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Wiskott-Aldrich Syndrome Global Clinical Trials Review, H2, 2014" provides data on the Wiskott-Aldrich ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H2, 2014

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • September 2014
  • by Global Data

Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Mucopolysaccharidosis II (MPS II) (Hunter Syndrome) Global Clinical ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2014

Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2014

  • $ 2 500
  • Industry report
  • September 2014
  • by Global Data

Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Hyperphosphatemia - Pipeline Review, H2 2014

Hyperphosphatemia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Hyperphosphatemia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Hyperphosphatemia - Pipeline Review, H2 2014', provides an overview of the Hyperphosphatemia's therapeutic pipeline. This ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Restenosis - Pipeline Review, H2 2014

Restenosis - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Restenosis - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Restenosis - Pipeline Review, H2 2014', provides an overview of the Restenosis's therapeutic pipeline. This report provides comprehensive ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Myotonic Dystrophy - Pipeline Review, H2 2014

Myotonic Dystrophy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Myotonic Dystrophy - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Myotonic Dystrophy - Pipeline Review, H2 2014', provides an overview of the Myotonic Dystrophy's therapeutic pipeline. ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Seizures - Pipeline Review, H2 2014

Seizures - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Seizures - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Seizures - Pipeline Review, H2 2014', provides an overview of the Seizures's therapeutic pipeline. This report provides comprehensive ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Grass Pollen Allergy - Pipeline Review, H2 2014

Grass Pollen Allergy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Grass Pollen Allergy - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Grass Pollen Allergy - Pipeline Review, H2 2014', provides an overview of the Grass Pollen Allergy's therapeutic pipeline. ...

  • Industries : Drug Discovery and Development
  • Countries : World, Canada
Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H2 2014

Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • November 2014
  • by Global Markets Direct

Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H2 2014', provides an overview of the Proliferative ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
High Triglyceridemia - Pipeline Review, H2 2014

High Triglyceridemia - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

High Triglyceridemia - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘High Triglyceridemia - Pipeline Review, H2 2014', provides an overview of the High Triglyceridemia's therapeutic pipeline. ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Pituitary ACTH Hypersecretion (Cushing%s Disease) - Pipeline Review, H2 2014

Pituitary ACTH Hypersecretion (Cushing%s Disease) - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • October 2014
  • by Global Markets Direct

Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H2 2014 Summary Global Markets Direct's, ‘Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Review, H2 2014', provides ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
Cleveland BioLabs, Inc. - Product Pipeline Review - 2014

Cleveland BioLabs, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Industry report
  • December 2014
  • by Global Markets Direct

Cleveland BioLabs, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Cleveland BioLabs, Inc. - Product Pipeline Review - 2014', provides an overview of the Cleveland BioLabs, Inc.'s ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Clinical Trial Support Services in the US - Industry Market Research Report

Clinical Trial Support Services in the US - Industry Market Research Report

  • $ 1 020
  • Industry report
  • November 2014
  • by Ibisworld

Clinical Trial Support Services The Clinical Trial Support Services industry provides preclinical trial preparation work, tracks and records results and data, as well as prepares information for regulatory ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Innocoll Technologies Ltd - Product Pipeline Analysis, 2014 Update

Innocoll Technologies Ltd - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

Summary Innocoll Technologies Ltd (Innocoll Technologies) is a biopharmaceutical company. The company develops and markets pharmaceutical products and medical devices for the pharmaceutical and medical ...

  • Industries : Drug Discovery and Development
  • Countries : United States, Ireland, India
Endoscape, Inc. - Product Pipeline Analysis, 2014 Update

Endoscape, Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • October 2014
  • by Global Data

Summary Endoscape, Inc. (Endoscape) is a medical device company. The company provides products for colon cancer screening. It offers products such as colon intubation assist device, advanced angulation ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Avastra Sleep Centres Limited - Strategic SWOT Analysis Review

Avastra Sleep Centres Limited - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Avastra Sleep Centres Limited (Avastra) is a publicly held Australia based company that operates diagnostic sleep centers. It is one of the largest networks of sleep specialists in the US. The ...

  • Industries : Drug Discovery and Development
  • Countries : Australia, United States
PharmaGap Inc. (Symbol:GAP) SWOT Analysis, Strategy, Revenues and Profits

PharmaGap Inc. (Symbol:GAP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug Discovery and Development
  • Countries : Canada
MIGENIX Inc. (BWESF) - Strategic SWOT Analysis Review

MIGENIX Inc. (BWESF) - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary MIGENIX Inc. (MIGENIX), formerly known as Micrologix Biotech Inc., is a publicly held bio-pharmaceutical company. It is principally engaged in researching, developing and commercializing drugs ...

  • Industries : Drug Discovery and Development
  • Countries : Canada
Almac Group Limited SWOT Analysis, Strategy, Revenues and Profits

Almac Group Limited SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Amazon BioTech - Strategic SWOT Analysis Review

Amazon BioTech - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • November 2014
  • by Global Data

Summary Amazon BioTech (Amazon) is a pharmaceutical company. The company researches and develops natural drugs for the treatment of HIV disease based on immune-based therapies. It's AMZ0026 - Amazon Biotech's ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Bruker Daltonics Inc. SWOT Analysis, Strategy, Revenues and Profits

Bruker Daltonics Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug Discovery and Development
  • Countries : United States
Cadus Corporation (Symbol:KDUS) SWOT Analysis, Strategy, Revenues and Profits

Cadus Corporation (Symbol:KDUS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug Discovery and Development
  • Countries : United States
FASgen, Inc. SWOT Analysis, Strategy, Revenues and Profits

FASgen, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug Discovery and Development
  • Countries : United States
NewBiotics, Inc. SWOT Analysis, Strategy, Revenues and Profits

NewBiotics, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Drug Discovery and Development
  • Countries : United States

17 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Pfizer Inc.

United States

General Hospital Corp.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.